Abstract

Xenograft is considered to be an attractive method to solve the severe shortage of organs. However, the major obstacle of pig-to-human xenotransplantation is antibody-mediated immunological rejection, referred as hyper acute rejection and acute humoral rejection which occurs if HAR is prevented. Functional ablation of alpha1,3-galactosyltransferase (alpha1,3-GalT) is the most powerful approach to prevent HAR. Alternatively, overexpression of human complement regulatory protein is known to efficiently decrease HAR and AHR. We developed a vector strategy to lead to disruption of alpha1,3-GalT function and concurrently expression of MCP. We synthesized two homologous region by PCR amplification, corresponding to α1,3-GalT to use 5' and 3' arms for its exon 9. To target separate MCP expression system at exon 9 of alpha1,3-GalT locus, we constructed two MCP expression cassettes, in which CMV and hEF1alpha promoter regulate respectively hMCP expression and IRES-mediated neomycin resistance gene expression. Two cassettes respectively were inserted between 5' and 3' arms (designated as GalT KO/CMV-MCPneo and GalT KO/hEF- MCPneo). The GalT KO/CMV-MCPneo vector was introduced in porcine ear skin fibroblasts using Nucelofector. Nine colonies were identified as targeted at exon 9 of alpha1,3-GalT locus by long-range PCR screening. Quantitative RT-PCR showed that MCP expression is up-regulated, and alpha1,3-GalT is down-regulated. Importantly, we showed that two colonies analyzed expressed efficiently MCP at cell surface. These selected fibroblasts can be used as donor for somatic cell nuclear transfer (BioGreen 21 Program, PJ0071872010). (poster)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call